NEW YORK, May 21 (GenomeWeb News) - Pharmacopeia has changed its name to Accelrys, the company said yesterday.

 

Stockholders approved the name change on May 11. After spinning off its drug discovery business, Accelrys is now solely focused on delivering scientific software to the life science and materials research industries.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.